Neonatal neurological disorders in Kansas City, Missouri

Dr. Ayanda Chakawa is a health institution located at 2401 Gillham Road in Kansas City, Missouri, United States. The institution is part of Children's Mercy, a renowned children's hospital with a focus on developmental and behavioral health. The hospital has received a Magnet Designation for excellence in nursing, placing it in the top 8 percent of hospitals nationally. It has also been recognized by U.S. News & World Report as one of America's best children's hospitals, with rankings in 9 specialties. By supporting Children's Mercy, you can bring hope, comfort, and brighter tomorrows to children and their families. Please note that the Children's Mercy Northland location will be open for Save My Spot appointments only on Friday, April 5. Walk-in appointments will not be available, so be sure to reserve your appointment time with Save My Spot. Children's Mercy is a 501(c)3 charitable organization dedicated to providing exceptional care to children in need.

Ara S. Hall MD is a renowned institution located at 2401 Gillham Road in Kansas City, Missouri, United States. Specializing in pediatric health, the institution offers a wide range of services including epilepsy treatment, neonatal neurology services, and neurophysiology lab testing. The Interim Section Chief of Epilepsy, Dr. Ara S. Hall, is also the Director of Neonatal Neurology Services and the Neurophysiology Lab. Dr. Hall is an Associate Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine and a Clinical Assistant Professor of Pediatrics at the University of Kansas School of Medicine. She received her MD from the University of Texas Health Science Center in Houston and completed her training in Child Neurology at the University of Colorado School of Medicine/Children's Hospital Colorado in Aurora.

Kevin F. Ginn MD is a renowned institution located at 2401 Gillham Road, Kansas City, Missouri, United States. Specializing in pediatric health, the institution is led by Dr. Kevin F. Ginn, who serves as the Interim Director of the Experimental Therapeutics Program and Director of the Brain Tumor Program. Dr. Ginn is also an Associate Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine and a Clinical Assistant Professor of Pediatrics at the University of Kansas School of Medicine. With a background in Pediatrics from Louisiana State University Health Sciences Center and Pediatric Neuro-Oncology from St. Jude Children's Research Hospital, Dr. Ginn brings a wealth of knowledge and expertise to his practice. The institution has been recognized with a Magnet Designation for excellence in nursing and has been voted as one of America's best children's hospitals by U.S. News & World Report.